Literature DB >> 3969331

Parent-specific adjustments for evaluation of recumbent length and stature of children.

J H Himes, A F Roche, D Thissen, W M Moore.   

Abstract

A clinical "parent-specific" method for evaluating recumbent length and stature of children, allowing for the stature of parents, is presented. This method uses midparent stature and allows adjustment of recumbent length (birth to 3 years) and stature (3 to 18 years) of US children relative to National Center for Health Statistics growth charts. The method is based on parent-child relationships for 586 midparent-child pairs participating in the Fels Longitudinal Study, and on more than 16,000 serial measurements of recumbent length and stature. The method provides a clinical tool to separate the normal genetic contribution of parental stature to stature of children from other factors that affect stature such as malnutrition or disease.

Entities:  

Mesh:

Year:  1985        PMID: 3969331

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Parent-specific evaluation of growth.

Authors:  J H Himes; A F Roche
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

2.  Evaluation of the child with short stature.

Authors:  S B Holmes
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

3.  Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening.

Authors:  Zhumin Zhang; Mary J Lindstrom; Philip M Farrell; HuiChuan J Lai
Journal:  Pediatrics       Date:  2016-04-05       Impact factor: 7.124

4.  Vitamin B(12) status in children with cystic fibrosis and pancreatic insufficiency.

Authors:  Asim Maqbool; Joan I Schall; Maria R Mascarenhas; Kelly A Dougherty; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

5.  Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; Paul R Gallagher; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

6.  Incorporating genetic potential when evaluating stature in children with cystic fibrosis.

Authors:  Zhumin Zhang; Suzanne M Shoff; Huichuan J Lai
Journal:  J Cyst Fibros       Date:  2010-03       Impact factor: 5.482

7.  Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; J Felipe Garcia-Espana; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

8.  Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis.

Authors:  Zhumin Zhang; Mary J Lindstrom; HuiChuan J Lai
Journal:  J Pediatr       Date:  2013-03-25       Impact factor: 4.406

9.  Genetic potential and height velocity during childhood and adolescence do not fully account for shorter stature in cystic fibrosis.

Authors:  Zofia N Zysman-Colman; Marissa J Kilberg; Victor S Harrison; Alessandra Chesi; Struan F A Grant; Jonathan Mitchell; Saba Sheikh; Denis Hadjiliadis; Michael R Rickels; Ronald C Rubenstein; Andrea Kelly
Journal:  Pediatr Res       Date:  2020-05-09       Impact factor: 3.756

10.  Factors affecting height velocity in normal prepubertal children.

Authors:  Jun Hui Lee; Seul Ki Kim; Eun Kyoung Lee; Moon Bae Ahn; Shin Hee Kim; Won Kyoung Cho; Kyoung Soon Cho; Min Ho Jung; Byung Kyu Suh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.